Cargando…
Exploitation of the chick embryo chorioallantoic membrane (CAM) as a platform for anti-metastatic drug testing
The establishment of clinically relevant models for tumor metastasis and drug testing is a major challenge in cancer research. Here we report a physiologically relevant assay enabling quantitative analysis of metastatic capacity of tumor cells following implantation into the chorioallantoic membrane...
Autores principales: | Pawlikowska, P., Tayoun, T., Oulhen, M., Faugeroux, V., Rouffiac, V., Aberlenc, A., Pommier, A. L., Honore, A., Marty, V., Bawa, O., Lacroix, L., Scoazec, J. Y., Chauchereau, A., Laplace-Builhe, C., Farace, F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547099/ https://www.ncbi.nlm.nih.gov/pubmed/33037240 http://dx.doi.org/10.1038/s41598-020-73632-w |
Ejemplares similares
-
CTC-Derived Models: A Window into the Seeding Capacity of Circulating Tumor Cells (CTCs)
por: Tayoun, Tala, et al.
Publicado: (2019) -
Tumor Evolution and Therapeutic Choice Seen through a Prism of Circulating Tumor Cell Genomic Instability
por: Tayoun, Tala, et al.
Publicado: (2021) -
Targeting genome integrity dysfunctions impedes metastatic potency in non–small cell lung cancer circulating tumor cell–derived explants
por: Tayoun, Tala, et al.
Publicado: (2022) -
Implementation of the Chick Chorioallantoic Membrane (CAM) Model in Radiation Biology and Experimental Radiation Oncology Research
por: Dünker, Nicole, et al.
Publicado: (2019) -
Circulating tumor cell copy-number heterogeneity in ALK-rearranged non-small-cell lung cancer resistant to ALK inhibitors
por: Oulhen, Marianne, et al.
Publicado: (2021)